Larry S. Seidman

Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.

R. Kroll, B. Howard, H. Weiss, 2015, Contraception.

A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: the speed of onset of therapeutic assessment trial (STAT).

D. Lama, P. Siami, Larry S. Seidman, 2002, Clinical therapeutics.

An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.

C. K. Skokos, Larry S. Seidman, 2005, Infectious diseases in obstetrics and gynecology.

A phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in women.

M. Gittelman, H. Weiss, Larry S. Seidman, 2014, The Journal of urology.

A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.

G. Constantine, D. Archer, J. Pickar, 2009, American journal of obstetrics and gynecology.

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)

K. Beusterien, A. Kivitz, W. Koltun, 2005, Current medical research and opinion.

Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies

R. Cady, A. Rodgers, F. Skobieranda, 2007, Headache.

Early perceptual loss in depression

Yonina C. Eldar, Karl J. Friston, Charles R. Seger, 2007 .

A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation

R. Kroll, B. Howard, H. Weiss, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)

K. Beusterien, A. Kivitz, W. Koltun, 2005 .

Return to Ovulatory Capacity With Three Combined Oral Contraceptive Regimens: A Comparative Trial

R. Kroll, J. Hsieh, Larry S. Seidman, 2014 .

REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause

G. Constantine, D. Archer, J. Pickar, 2009 .